Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Current-Assets" stands at 55.39 Billion Japanese Yens as of 09/30/2025, the lowest value since 12/31/2023.
As of the end of Astellas Pharma Inc.'s second quarter, the item "Other Current Assets" stands at 55.39 Billion JPY. This represents a decrease of -46.42 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -29.80 percent compared to the value the year prior.
The 1 year change in percent is -29.80.
The 3 year change in percent is 23.08.
The 5 year change in percent is 49.73.
The 10 year change in percent is 110.73.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Current Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Current Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Current Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Current Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Current Assets | 280,205,508,085.11 |